# ACUTE LIVER FAILURE (ALF)

## 定義

• Acute insult to liver + coagulopathy + encephalopathy; most without known preexisting liver dis.

• _Hyperacute_ if encephalopathy <7 d from jaundice onset; _acute_ if 7–21 d, _subacute_ if >21 d

• Acute on chronic liver failure: acute insult to liver in Pt with underlying chronic liver disease

## Etiology (_J Hepatol_ 2015;62:S112)

### • **Drugs**/**toxins** (nearly 80% of cases in U.S.; _Gastro_ 2015;148:1353, _Clin Liver Dis_ 2017;21:151)

Drugs: acetaminophen (most common cause; >40% of all cases in U.S., typically unintentional overdose); anti-TB drugs (INH, rifampin, pyrazinamide); AEDs (phenytoin, valproate, carbamazepine); NSAIDs (idiosyncratic, not dose related); 抗生素 (eg, fluoroquinolones, macrolides); MDMA (ecstasy)

Toxins: _Amanita phalloides_ (mushroom sp. in West Coast), certain herbal preparations

• **Viral** (12% of cases in the U.S.): HAV, HBV, HCV (rare), HDV + HBV, HEV (esp. if pregnant). In immunosupp: HSV (50% have skin lesions), EBV, VZV, CMV, HHV6

• **Vascular:** Budd-Chiari, ischemic hepatitis, hepatic sinusoidal obstructive syndrome

• **Other:** Wilson disease, pregnancy-related ALF (acute fatty liver, preeclampsia, HELLP), initial presentation of autoimmune hepatitis; idiopathic

## 臨床表現

• Initial presentation usually nonspecific: n/v, malaise; then jaundice & multiorgan failure

• Neurologic: **encephalopathy:** grade 1 = attn deficit, tremor; grade 2 = _asterixis_, lethargy, confusion, ataxia; grade 3 = somnolence, rigidity, clonus, hyporeflexia; grade 4 = coma

**cerebral edema:** astrocyte swelling likely related to ↑ ammonia levels

• Cardiovascular: **hypotension** with low SVR, shock

• Pulmonary: **respiratory alkalosis**, impaired peripheral O2 uptake, pulm edema, ARDS

• GI: bleeding (due to bleeding diathesis), pancreatitis (? due to ischemia, drugs, infxn)

• Renal: ATN, **hepatorenal syndrome**, hyponatremia, hypokalemia, hypophosphatemia

• Hematology: thrombocytopenia, ↑ PT/PTT, ↓ fibrinogen, **bleeding diathesis** (↓ synthesis of coag factors balanced by ↓ protein C/S; bleeding mostly due to low platelet count), DIC

• **Infection** (~90% of 病人): espec. with _Staph_, _Strep_, GNRs and fungi (↓ immune fxn, invasive procedures); SBP in 32% of 病人; _fever and_ ↑ _WBC may be absent_

• Endocrine: **hypoglycemia** (↓ glc synthesis), metabolic acidosis (↑ lactate), adrenal insuf.

## Workup (_Clin Liver Dis_ 2017;21:769)

• CBC, PT/PTT, LFTs, lytes, BUN/Cr, NH3, pH, _arterial_ lactate, acetaminophen level, HIV, amylase/lipase, viral serologies (qv) in all 病人, with additional labs as below if suspected

• Autoimmune hep serologies & IgG levels, ceruloplasmin & serum/urine copper, preg test

• Imaging studies (RUQ U/S or abd CT, Doppler studies of portal and hepatic veins)

• Liver biopsy if underlying etiology remains elusive after initial testing

## Management (_J Clin Exp Hepatol_ 2015;5:S104)

• **ICU care at liver transplant center** for hemodynamic & ventilatory support; CVVH for AKI

• Early listing for liver transplantation in selected 病人 (see below)

• Cerebral edema: consider ICP monitoring if grade 3/4 enceph; if ↑ ICP → mannitol 0.5–1.0 mg/kg; if arterial NH3 >150, grade 3/4 enceph, AKI or on vasopressors → prophylactic 3% saline for goal Na 145–155 mEq/L; barbiturates & hypothermia if refractory ↑ ICP

• Encephalopathy: intubate for grade 3 or 4; lactulose is of little benefit & may be detrimental

• Coagulopathy: vit K, FFP/plts/cryo if active bleeding or before invasive procedure; PPI ppx

• Infection: low threshold for 抗生素 (broad spectrum, eg, vancomycin & 3rd\-gen ceph.) if suspect infection; anti-fungal coverage in high-risk 病人

• Rx of specific causes: NAC if acetaminophen; antiviral for HBV; plasma exchange can be temporizing measure for Wilson disease; IV acyclovir for HSV; PCN-G for _A. phalloides;_ delivery of child for pregnancy-related; TIPS, anticoag for Budd-Chiari. Lack of data for use of steroids in autoimmune, but often given (_Hepatology_ 2014;59:612).

• NAC may benefit 病人 with non-APAP ALF but data inconclusive (_Clin Drug Investig_ 2017;37:473)

• Liver Tx if poor prog. but could survive surg. Extracorp liver support (molec. adsorbent recirc. system, MARS) & high-volume plasma exchange being studied (_J Hepatol_ 2016;64:69).

## Prognosis (_Ann Intern Med_ 2016;164:724; _World J Gastro_ 2016;22:1523)

• Non-acetaminophen ALF mortality ~70%, acetaminophen-induced ALF mortality ~25–30%

• Predictors of poor outcome (King’s College Hospital, UK):

Acetaminophen-induced: pH <7.25, INR >6.5 or PT>100, Cr >3.4, or grade 3/4 enceph.

Non-acetamin.-induced: INR >6.5 or PT>100; _or_ ≥3 of the following: unfavorable etiology (seronegative hepatitis or drug reaction); age <10 or >40 y; INR >3.5 or PT >50; Tbili >17.5; duration of jaundice >7 d prior to onset of encephalopathy

• ~20–25% of 病人 undergo liver transplantation with 5-y survival rate of 75%

• BMI >30, Cr >2, age >50 y, pressors/vent support a/w poorer acute transplant outcome
